Get the Stockscreener App
0.431
0.23%
0.001
After Hours:
.43
-0.001
-0.23%
Hcw Biologics Inc stock is traded at $0.431, with a volume of 92,866.
It is up +0.23% in the last 24 hours and down -4.33% over the past month.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
See More
Previous Close:
$0.43
Open:
$0.4515
24h Volume:
92,866
Relative Volume:
3.71
Market Cap:
$17.02M
Revenue:
$3.92M
Net Income/Loss:
$-38.37M
P/E Ratio:
-0.8288
EPS:
-0.52
Net Cash Flow:
$-22.41M
1W Performance:
-2.27%
1M Performance:
-4.33%
6M Performance:
-67.59%
1Y Performance:
-73.06%
1-Day Range:
$0.43
$0.49
1-Week Range:
$0.43
$0.528
52-Week Range:
$0.40
$1.93
Hcw Biologics Inc Stock (HCWB) Company Profile
Name
Hcw Biologics Inc
Sector
Industry
Phone
954-842-2024
Address
2929 N COMMERCE PKWY, MIRAMAR
Hcw Biologics Inc Stock (HCWB) Latest News
Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 212.2% in September - Defense World
Before You Invest, Make Sure You Check This Herbalife Ltd (NYSE: HLF) Analysis - Stocks Register
Hood River Capital Management LLC Acquires New Shares in Super Hi International Holding Ltd. (NASDAQ:HDL) - Defense World
Intech Investment Management LLC Makes New Investment in Hancock Whitney Co. (NASDAQ:HWC) - MarketBeat
HashiCorp (NASDAQ:HCP) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Hiscox (OTCMKTS:HCXLF) Trading Down 8.4% - Defense World
HealthCo Announces Latest Quarterly Distribution - TipRanks
HashiCorp CFO sells over $600k in company stock By Investing.com - Investing.com UK
HilleVax Inc (HLVX) can make a big difference with a little luck - SETE News
Investing in Herbalife Ltd (HLF): What You Must Know - Knox Daily
Morse Asset Management Inc Invests $701,000 in Hercules Capital, Inc. (NYSE:HTGC) - MarketBeat
HilleVax, Inc. (NASDAQ:HLVX) Given Consensus Rating of “Hold” by Analysts - Defense World
Herbalife Ltd. (NYSE:HLF) Given Average Rating of “Hold” by Analysts - Defense World
Huber Capital Management LLC Boosts Stock Position in Herbalife Ltd. (NYSE:HLF) - Defense World
HCW Biologics changes auditor, cites no disagreements - Investing.com India
Hsbc Holdings PLC Boosts Stock Holdings in CDW Co. (NASDAQ:CDW) - Defense World
Truist Financial Lowers Hancock Whitney (NASDAQ:HWC) Price Target to $56.00 - MarketBeat
Church & Dwight Co., Inc. (NYSE:CHD) Shares Purchased by Hsbc Holdings PLC - Defense World
HCW Biologics (NASDAQ:HCWB) Trading Down 16% - Defense World
Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat
Hagga, a Supernatural Thriller, Set to Release on September 20th - EIN News
FDA Inspection Preparedness and Compliance Seminar: Information and for Tools Pharmaceutical, Biopharmaceutical, Biologics and Medical Device Professionals | ON-DEMAND - GlobeNewswire Inc.
HCW Biologics (NASDAQ:HCWB) Shares Up 4.3% - Defense World
HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsCorrection - GlobeNewswire
Alopecia Areata Clinical Trials 2024: FDA Approvals, Pipeline, - openPR
HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024 - MSN
HCW Biologics Second Quarter 2024 Earnings: US$0.40 loss per share (vs US$0.12 loss in 2Q 2023) - Simply Wall St
Bullish HCW Biologics Insider Buying Worth US$2.57m Yet To Pay Off - Yahoo Finance
Insiders' US$2.57m Investments In Red Following HCW Biologics' US$3.7m Dip In Market Value - Simply Wall St
HCW Biologics faces Nasdaq delisting over share price, value By Investing.com - Investing.com Australia
HCW Biologics faces Nasdaq delisting over share price, value - Investing.com
HCW Biologics (NASDAQ:HCWB) Trading Down 3.3% - Defense World
HCW Biologics settles arbitration with ImmunityBio entities By Investing.com - Investing.com Nigeria
HCW Biologics settles arbitration with ImmunityBio entities - Investing.com
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts - GlobeNewswire
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key CompaniesFibroGen, OSE Immunotherapeutics, Panbela Therapeutics, Lokon Pharma, Helix Biopharma, Tvardi Therapeutics, BioNTech, XBiotech, Lumicell, CARsgen Ther - Yahoo Finance
Oncolytic Viruses: Unlocking a New Era in Cancer Immunotherapy | DelveInsight - PR Newswire UK
Recent gains in HCW Biologics Inc. (NASDAQ:HCWB) help add back some value on insider purchases worth US$6.8m ... - Yahoo New Zealand News
HCW Biologics Stock Soars after Receiving FDA Clearance for Phase 1 Trial - Yahoo News UK
HCW Biologics (NASDAQ:HCWB) Shares Down 8.9% - Defense World
Trillion Energy International (OTCMKTS:TCFF) Shares Down 0.6% - Defense World
HCW Biologics Shareholders Elect Director, Ratify Auditor By Investing.com - Investing.com
Financial Contrast: Nurix Therapeutics (NASDAQ:NRIX) versus HCW Biologics (NASDAQ:HCWB) - Defense World
Snowflake (SNOW) Shares Skyrocket, What You Need To Know - The Globe and Mail
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
(PDF) Development of a Destabilized Firefly Luciferase Enzyme for Measurement of Gene Expression - ResearchGate
HCW Biologics Warns of Ability to Continue Operating Without Additional Funds - MarketWatch
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights - Investing News Network
Will Nvidia Follow AMD, Intel, and Super Micro and Plummet After Reporting Earnings? - The Globe and Mail
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights - Yahoo Finance
Hcw Biologics Inc Stock (HCWB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):